T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients - Concepedia

Concepedia

Publication | Closed Access

T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients

88

Citations

30

References

2014

Year

Wěi Li, Shengxiang Ren, Jiayu Li, Aiwu Li, Lihong Fan, Xuefei Li, Cao Zhao, Yayi He, Guanghui Gao, Xiaoxia Chen,

Clinical TranslationMedicineBetter EfficacyPathologyAdvanced Nsclc PatientsT790m MutationCancer GeneticsOncologyRadiation OncologyNovel TherapyTumor BiologyVariant Interpretation

References

	Year	Citations

Page 1

Page 1